Thiol redox state and oxidative stress in midbrain and striatum of weaver mutant mice, a genetic model of nigrostriatal dopamine deficiency

Neuroscience Letters

Volumn 376, Issue 1, 2005, Pages 24-28

  Patsoukis, Nikolaos ^a   Papapostolou, Ioannis ^a   Zervoudakis, George ^a   Georgiou, Christos D ^a   Matsokis, Nikolaos A ^a   Panagopoulos, Nikolaos T ^a  

^a UNIVERSITY OF PATRAS   (Greece)

Author keywords

Dopaminergic neurodegeneration; Lipid peroxidation; Midbrain; Oxidative stress; Striatum; Thiol redox state; Weaver

Indexed keywords

CYSTEINE; DISULFIDE; DOPAMINE; GLUTATHIONE; GLUTATHIONE DISULFIDE; LIPID; MALONALDEHYDE; PROTEIN; THIOL;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; CORRELATION ANALYSIS; DISEASE SEVERITY; DOPAMINE BRAIN LEVEL; DOPAMINERGIC NERVE CELL; DOPAMINERGIC SYSTEM; GENETIC MODEL; LIPID PEROXIDATION; MALE; MESENCEPHALON; MOUSE; MOUSE MUTANT; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; STRIATONIGRAL DEGENERATION;

EID: 13444257809     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2004.11.019     Document Type: Article

References (43)

1. A.-P. Arrigo Gene expression and the thiol redox state Free Radic. Biol. Med. 27 1999 936 944
2. V. Calabrese, N. Ragusa, A. Antico, S. Mangiameli, and V. Rizza Cysteine-induced enhancement of lipid peroxidation in substantia nigra: comparative effect with exogenous administration of reduced glutathione Drugs Exp. Clin. Res. 23 1997 25 31
3. D.T. Dexter, C.J. Carter, F.R. Wells, F. Javoy-Agid, Y. Agid, A. Lees, P. Jenner, and C.D. Marsden Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease J. Neurochem. 52 1989 381 389
4. R. Dringen Metabolism and functions of glutathione in brain Prog. Neurobiol. 62 2000 649 671
5. S.B. Dunnett, and A. Bjorklund Prospects for new restorative and neuroprotective treatments in Parkinson's disease Nature 399 1999 32 39
6. J.M. Fearnley, and A.J. Lees Ageing and Parkinson's disease: substantia nigra regional selectivity Brain 114 1991 2283 2301
7. B. Halliwel C.M.J. Gutteridge Free Radicals in Biology and Medicine third ed. 1999 Oxford University Press Oxford 936 pp
8. A.B. Harkins, S. Dlouhy, B. Ghetti, A.L. Cahill, L. Won, B. Heller, A. Heller, and A.P. Fox Evidence of elevated intracellular calcium levels in weaver homozygote mice J. Physiol. 524 2000 447 455
9. M.T. Heafield, S. Fearn, G.B. Steventon, R.H. Waring, A.C. Williams, and S.G. Sturman Plasma cysteine and sulphate levels in patients with motor neurone, Parkinson's and Alzheimer's disease Neurosci. Lett. 110 1990 216 220
10. R. Janáky, K. Ogita, B.A. Pasqualotto, J.S. Bains, S.S. Oja, Y. Yoneda, and C.A. Shaw Glutathione and signal transduction in the mammalian CNS J. Neurochem. 73 1999 889 902
11. R. Janáky, V. Varga, A. Hermann, P. Saransaari, and S.S. Oja Mechanisms of L-cysteine neurotoxicity Neurochem. Res. 25 2000 1397 1405 (review)
12. P. Jenner Oxidative stress in Parkinson's disease Ann. Neurol. 53 Suppl. 3 2003 S26 S36 (discussion S36-S38, review)
13. R.L. Karlsen, I. Grofova, D. Malthe-Sorenssen, and F. Fonnum Morphological changes in rat brain induced by L-cysteine injection in newborn animals Brain Res. 208 1981 167 180
14. J.G. Klingman, D.M. Hartley, and D.W. Choi Automated determination of excitatory amino acid neurotoxicity in cortical culture J. Neurosci. Methods 31 1990 47 51
15. + channel and rescue of weaver granule cells Neuron 16 1996 941 952
16. N. Lev, E. Melamed, and D. Offen Apoptosis and Parkinson's disease Prog. Neuropsychopharmacol. Biol. Psychiatry 27 2003 245 250 (review)
17. T.J. Montine, V. Amarnath, M.J. Picklo, K.R. Sidell, J. Zhang, and D.G. Graham Dopamine mercapturate can augment dopaminergic neurodegeneration Drug Metab. Rev. 32 2000 363 376
18. T.J. Montine, M.J. Picklo, V. Amarnath, W.O. Whetsell Jr., and D.G. Graham Neurotoxicity of endogenous cysteinylcatechols Exp. Neurol. 148 1997 26 33
19. A.M. Muñoz, P. Rey, R. Soto-Otero, M.J. Guerra, and J.L. Labandeira-Garcia Systemic administration of N-acetylcysteine protects dopaminergic neurons against 6-hydroxydopamine-induced degeneration J. Neurosci. Res. 76 2004 551 562
20. D. Offen, I. Ziv, H. Sternin, E. Melamed, and A. Hochman Prevention of dopamine-induced cell death by thiol antioxidants: possible implications for treatment of Parkinson's disease Exp. Neurol. 141 1996 32 39
21. J.W. Olney, C. Zorumski, M.T. Price, and J. Labruyere L-Cystine a bicarbonate-sensitive endogenous excitotoxin Science 248 1990 596 599
22. T.F. Oo, R. Blazeski, S.M.W. Harrison, C. Henchcliffe, C.A. Mason, S.K. Roffler-Tarlov, and R.E. Burke Neuron death in the substantia nigra in weaver mouse occurs late in development and is non-apoptotic J. Neurosci. 16 1996 6134 6135
23. N. Patil, D.R. Cox, D. Bhat, M. Faham, R.M. Myers, and A.S. Peterson A potassium channel mutation in weaver mice implicates membrane excitability in granule cell differentiation Nat. Genet. 11 1995 126 129
24. N. Patsoukis, and C.D. Georgiou Determination of the thiol redox state of organisms: new oxidative stress indicators Anal. Bioanal. Chem. 378 2004 1783 1792
25. T.L. Perry, D.V. Godin, and S. Hansen Parkinson's disease: a disorder due to nigral glutathione deficiency? Neurosci. Lett. 33 1982 305 310
26. T.L. Perry, V.W. Yong, K. Jones, and J.M. Wright Manipulation of glutathione contents fails to alter dopaminergic nigrostriatal neurotoxicity of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the mouse Neurosci. Lett. 70 1986 261 265
27. S. Roffler-Tarlov, and A.M. Graybiel Weaver mutation has differential effects on the dopamine-containing innervation of the limbic and nonlimbic striatum Nature 307 1984 62 66
28. S. Roffler-Tarlov, and A.M. Graybiel Expression of the weaver gene in dopamine-containing neural systems is dose-dependent and affects both striatal and nonstriatal regions J. Neurosci. 6 1986 3319 3330
29. P. Rossi, G. De Filippi, S. Armano, V. Taglietti, and E. D'Angelo The weaver mutation causes a loss of inward rectifier current regulation in premigratory granule cells of the mouse cerebellum J. Neurosci. 18 1998 3537 3547
30. M.J. Schmidt, B.D. Sawyer, K.W. Perry, R.W. Fuller, M.M. Foreman, and B. Ghetti Dopamine deficiency in the weaver mutant mouse J. Neurosci. 2 1982 376 380
31. M. Sekiguchi, R.S. Nowakowski, Y. Nagato, O. Tanaka, H. Guo, M. Madoka, and H. Abe Morphological abnormalities in the hippocampus of the weaver mutant mouse Brain Res. 696 1995 262 267
32. X.M. Shen, F. Zhang, and G. Dryhurst Oxidation of dopamine in the presence of cysteine: characterization of new toxic products Chem. Res. Toxicol. 10 1997 147 155
33. J. Sian, D.T. Dexter, A.J. Lees, S. Daniel, P. Jenner, and C.D. Marsden Glutathione-related enzymes in brain in Parkinson's disease Ann. Neurol. 36 1994 356 361
34. S.K. Silverman, P. Kofuji, D.A. Dougherty, N. Davidson, and H.A. Lester A regenerative link in the ionic fluxes through the weaver potassium channel underlies the pathophysiology of the mutation Proc. Natl. Acad. Sci. U.S.A. 93 1996 15429 15434
35. J.R. Simon, and B. Ghetti The weaver mutant mouse as a model of nigrostriatal dysfunction Mol. Neurobiol. 9 1994 183 189
36. + channels Neuron 16 1996 321 331
37. J.P.E. Spencer, P. Jenner, S.E. Daniel, A.J. Lees, D.C. Marsden, and B. Halliwell Conjugates of catecholamines with cysteine and GSH in Parkinson's disease: possible mechanisms of formation involving reactive oxygen species J. Neurochem. 71 1998 2112 2122
38. + current in cerebellar granule cells Proc. Natl. Acad. Sci. U.S.A. 93 1996 11191 11195
39. F. Tietze Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues Anal. Biochem. 27 1960 502 522
40. S. Toffa, G.M. Kunikowska, B.Y. Zeng, P. Jenner, and C.D. Marsden Glutathione depletion in rat brain does not cause nigrostriatal pathway degeneration J. Neural Transm. 104 1997 67 75
41. L.C. Triarhou, J. Norton, and B. Ghetti Mesencephalic dopamine cell deficit involves areas A8, A9 and A10 in weaver mutant mice Exp. Brain Res. 70 1988 256 265
42. C. Verney, A. Febvret-Muzerelle, and P. Gaspar Early postnatal changes of the dopaminergic mesencephalic neurons in the weaver mutant mouse Dev. Brain Res. 89 1995 115 119
43. M. Womack, K. Thompson, E. Fanselow, G.J. Augustine, and A. Peterson Elevated intracellular calcium levels in cerebellar granule neurons of weaver mice Neuroreport 9 1998 3391 3395